← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Chief Medical Officer Kenneth Pienta sold $41K of Cue Biopharma, Inc.

Sold$40,980
$15.07Price
2,720Shares
−58%Stake

What CUE did after the filing

Prices for CUE after this filing aren't in yet.

Traded Wed, Jan 20. Filed Thu, Feb 18. Not investment advice.